1.Effects of Local Pancreatic Renin-Angiotensin System on the Microcirculation of Rat with Severe Acute Pancreatitis.
Zhijian PAN ; Ling FENG ; Haocheng LONG ; Hui WANG ; Jiarui FENG ; Feixiang CHEN
The Korean Journal of Physiology and Pharmacology 2015;19(4):299-307
Severe acute pancreatitis (SAP) is normally related to multiorgan dysfunction and local complications. Studies have found that local pancreatic renin-angiotensin system (RAS) was significantly upregulated in drug-induced SAP. The present study aimed to investigate the effects of angiotensin II receptors inhibitor valsartan on dual role of RAS in SAP in a rat model and to elucidate the underlying mechanisms. 3.8% sodium taurocholate (1 ml/kg) was injected to the pancreatic capsule in order for pancreatitis induction. Rats in the sham group were injected with normal saline in identical locations. We also investigated the regulation of experimentally induced SAP on local RAS expression in the pancreas through determination of the activities of serum amylase, lipase and myeloperoxidase, histological and biochemical analysis, radioimmunoassay, fluorescence quantitative PCR and Western blot analysis. The results indicated that valsartan could effectively suppress the local RAS to protect against experimental acute pancreatitis through inhibition of microcirculation disturbances and inflammation. The results suggest that pancreatic RAS plays a critical role in the regulation of pancreatic functions and demonstrates application potential as AT1 receptor antagonists. Moreover, other RAS inhibitors could be a new therapeutic target in acute pancreatitis.
Amylases
;
Animals
;
Blotting, Western
;
Fluorescence
;
Inflammation
;
Intercellular Adhesion Molecule-1
;
Lipase
;
Microcirculation*
;
Models, Animal
;
P-Selectin
;
Pancreas
;
Pancreatitis*
;
Peroxidase
;
Polymerase Chain Reaction
;
Radioimmunoassay
;
Rats*
;
Receptors, Angiotensin
;
Renin-Angiotensin System*
;
Taurocholic Acid
;
Valsartan
2.Comparisons of efficacy and safety of CBV, BEAM and BEAC high-dose therapy followed by autologous hematopoietic stem cell transplantation in Hodgkin's lymphoma
Youwu SHI ; Peng LIU ; Shengyu ZHOU ; Jianliang YANG ; Xiaohong HAN ; Xiaohui HE ; Changgong ZHANG ; Lin GUI ; Yan QIN ; Sheng YANG ; Liya ZHAO ; Jiarui YAO ; Shuxiang ZHANG ; Shikai WU ; Feng PAN ; Yan SUN ; Yuankai SHI
Chinese Journal of Hematology 2017;38(8):716-719
3.Advance in pyroptosis in animals infectious diseases
Ruxin ZHANG ; Huimei LIANG ; Huan ZENG ; Chen GUO ; Jingyi QI ; Jiarui PAN ; Beining WU ; Qiyi CHEN ; Houhui SONG ; Wei WANG ; Jinghua ZHAO
Chinese Journal of Veterinary Science 2024;44(9):2072-2080
Pyroptosis is a programmed death of inflammatory cells triggered by pathogen invasion,dependent on caspase activation,through both classical and non-classical pyroptosis pathways.Cell pyroptosis is related to the occurrence and development of a variety of animal infectious diseases caused by microbial infection.After microorganisms invading,cells are stimulated by pathology-re-lated molecular patterns,causing strong immune response,stimulating inflammatory signaling pathways,and then activating inflammasome,leading to pyroptosis.The immune system has e-volved multiple mechanisms to fight microbial infections and regulate inflammatory responses.The innate immune system,by recognizing microbial molecules in pathogens and responding quickly by producing inflammasome and activating pyroptosis,helps clear pathogens to prevent infection and maintain the normal functioning of the body.A thorough study of the pathogenesis and immune es-cape mechanism of cell pyroptosis in animal infectious diseases will provide a new direction for the treatment of animal infectious diseases.
4.Low diastolic blood pressure and adverse outcomes in inpatients with acute exacerbation of chronic obstructive pulmonary disease: A multicenter cohort study.
Chen ZHOU ; Qun YI ; Yuanming LUO ; Hailong WEI ; Huiqing GE ; Huiguo LIU ; Xianhua LI ; Jianchu ZHANG ; Pinhua PAN ; Mengqiu YI ; Lina CHENG ; Liang LIU ; Jiarui ZHANG ; Lige PENG ; Adila AILI ; Yu LIU ; Jiaqi PU ; Haixia ZHOU
Chinese Medical Journal 2023;136(8):941-950
BACKGROUND:
Although intensively studied in patients with cardiovascular diseases (CVDs), the prognostic value of diastolic blood pressure (DBP) has little been elucidated in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This study aimed to reveal the prognostic value of DBP in AECOPD patients.
METHODS:
Inpatients with AECOPD were prospectively enrolled from 10 medical centers in China between September 2017 and July 2021. DBP was measured on admission. The primary outcome was all-cause in-hospital mortality; invasive mechanical ventilation and intensive care unit (ICU) admission were secondary outcomes. Least absolute shrinkage and selection operator (LASSO) and multivariable Cox regressions were used to identify independent prognostic factors and calculate the hazard ratio (HR) and 95% confidence interval (CI) for adverse outcomes.
RESULTS:
Among 13,633 included patients with AECOPD, 197 (1.45%) died during their hospital stay. Multivariable Cox regression analysis showed that low DBP on admission (<70 mmHg) was associated with increased risk of in-hospital mortality (HR = 2.16, 95% CI: 1.53-3.05, Z = 4.37, P <0.01), invasive mechanical ventilation (HR = 1.65, 95% CI: 1.32-2.05, Z = 19.67, P <0.01), and ICU admission (HR = 1.45, 95% CI: 1.24-1.69, Z = 22.08, P <0.01) in the overall cohort. Similar findings were observed in subgroups with or without CVDs, except for invasive mechanical ventilation in the subgroup with CVDs. When DBP was further categorized in 5-mmHg increments from <50 mmHg to ≥100 mmHg, and 75 to <80 mmHg was taken as reference, HRs for in-hospital mortality increased almost linearly with decreased DBP in the overall cohort and subgroups of patients with CVDs; higher DBP was not associated with the risk of in-hospital mortality.
CONCLUSION:
Low on-admission DBP, particularly <70 mmHg, was associated with an increased risk of adverse outcomes among inpatients with AECOPD, with or without CVDs, which may serve as a convenient predictor of poor prognosis in these patients.
CLINICAL TRIAL REGISTRATION
Chinese Clinical Trail Registry, No. ChiCTR2100044625.
Humans
;
Blood Pressure
;
Pulmonary Disease, Chronic Obstructive/therapy*
;
Cohort Studies
;
Respiration, Artificial
;
Inpatients
;
Hospital Mortality
5.Neuroprotective effects of Longxue Tongluo Capsule on ischemic stroke rats revealed by LC-MS/MS-based metabolomics approach.
Jing SUN ; Xianyang CHEN ; Yongru WANG ; Yuelin SONG ; Bo PAN ; Bei FAN ; Fengzhong WANG ; Xiaonan CHEN ; Pengfei TU ; Jiarui HAN ; Huixia HUO ; Jun LI
Chinese Herbal Medicines 2023;15(3):430-438
OBJECTIVE:
The present study aimed to evaluate the therapeutic effect and explore the underlying mechanisms of Longxue Tongluo Capsule (LTC) on ischemic stroke rats.
METHODS:
Twenty-six rats were randomly divided into four groups, including sham group, sham + LTC group, MCAO group, and MCAO + LTC group. Ischemic stroke rats were simulated by middle cerebral artery occlusion (MCAO), and LTC treatment group were orally administrated with 300 mg/kg of LTC once daily for seven consecutive days. LTC therapy was validated in terms of neurobehavioral abnormality evaluation, cerebral infarct area, and histological assessments. The plasma metabolome comparisons amongst different groups were conducted by UHPLC-Q Exactive MS in combination with subsequent multivariate statistical analysis, aiming to finding the molecules in respond to the surgery or LTC treatment.
RESULTS:
Intragastric administration of LTC significantly decreased not only the neurobehavioral abnormality scores but also the cerebral infarct area of MCAO rats. The interstitial edema, atrophy, and pyknosis of glial and neuronal cells occurred in the infarcted area, core area, and marginal area of cerebral cortex were improved after LTC treatment. A total of 13 potential biomarkers were observed, and Youden index of 11 biomarkers such as LysoPC, SM, and PE were more than 0.7, which were involved in neuroprotective process. The correlation and pathway analysis showed that LTC was beneficial to ischemic stroke rats via regulating glycerophospholipid and sphingolipid metabolism, together with nicotinate and nicotinamide metabolism. Heatmap and ternary analysis indicated the synergistic effect of carbohydrates and lipids may be induced by flavonoid intake from LTC.
CONCLUSION
The present study could provide evidence that metabolomics, as systematic approach, revealed its capacity to evaluate the holistic efficacy of TCM, and investigate the molecular mechanism underlying the clinical treatment of LTC on ischemic stroke.